Health Product InfoWatch – October 2021

Monthly recap of health product safety information. The following is a list of health product advisories, type I recalls and summaries of completed safety reviews published in September 2021 by Health Canada.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 17:37 (TU)
Créé le avril 17, 2026, 17:37 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-10-28 00:00:00
open_canada_keywords {"fr": ["InfoVigilance", "produits", "santé", "octobre", "2021", "COVID", "pandémie", "COVID-19", "Coronavirus", "Comorbidité", "surmortalité", "Agents", "contraste", "base", "gadolinium", "CellCept", "(mofétilmycophénolate)", "Glucagon", "Losartan", "Lumakras", "(sotorasib)", "Mirvala 28", "Pemazyre (pemigatinib)", "Truseltiq", "(infigratinib)", "Zepzelca", "(lurbinectédine)", "Zyloprim", "(allopurinol)"], "en": ["pandemic", "COVID-19", "Coronavirus", "COVID", "Health", "Product", "InfoWatch", "October", "2021", "Pharmaceuticals", "biologics", "CellCept", "(mycophenolate mofetil)", "Gadolinium-based", "contrast agents", "Glucagon", "Losartan", "Lumakras (sotorasib)", "Mirvala 28", "Pemazyre (pemigatinib)", "Truseltiq (infigratinib)", "Zepzelca (lurbinectedin)", "Zyloprim (allopurinol)", "Coronavirus disease", "(COVID-19)", "Monthly recap", "New information", "Vaccine", "safety", "biannual", "summary", "January 1", "2020", "June 30", "2020", "Product monograph", "update", "CellCept", "(mycophenolate mofetil)", "Zyloprim", "(allopurinol)", "Lumakras", "(sotorasib)", "Pemazyre", "(pemigatinib)", "Truseltiq", "(infigratinib)", "Notice", "market", "authorization", "conditions", "Zepzelca", "(lurbinectedin)", "Scope", "Reporting", "Adverse", "Reactions"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr InfoVigilance sur les produits de santé – octobre 2021
update_frequency P1M